Stockreport

Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million [Yahoo! Finance]

Scinai Immunotherapeutics Ltd. - American Depositary Shares  (SCNI) 
PDF focused on developing inflammation and immunology (I&I) biological products and on providing CDMO services through its Scinai Bioservices business unit, today published [Read more]